{
    "code": "02023388",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023388",
    "time": "2017-02-10 03:03:52",
    "許可證字號": "衛署藥輸字第023388號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/03\/01",
    "發證日期": "91\/03\/01",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202338807",
    "中文品名": "脂黴素微脂粒凍晶乾粉注射劑",
    "英文品名": "AMBISOME FOR INJECTION",
    "適應症": "1.骨髓移植後併發腎毒性出現侵入性黴菌感染。2.腎功能不全之麴菌屬、念珠菌屬或囊球菌屬類的菌種感染病患。3.治療感染囊球菌腦膜炎的HIV患者。4.治療麴菌屬、念珠菌屬或是囊球菌屬類的菌種感染，或是無法用AMPHOTERICIN B DEOXYCHOLATE治療的病患，或是腎功能不全或無法耐受AMPHOTERICIN B DEOXYCHOLATE所產生的毒性之病患。5.治療臟器的利時曼氏病。在免疫不全且患有臟器的利時曼氏病之患者使用AMBISOME治療，在初期寄生蟲清除後仍有高復發率。6.對發燒的重度嗜中性白血球缺乏症患者可能罹患黴菌感染症之經驗療法。",
    "劑型": "247凍晶乾粉注射劑",
    "包裝": "每盒100支以下小瓶",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "AMPHOTERICINB"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620117L277  香港商吉立亞醫藥有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F460346000  GILEAD SCIENCES INC.",
        "製造廠廠址": "650 CLIFFSIDE DRIVE, SAN DIMAS, CA91773; 502 COVINA BOULEVARD, SAN DIMAS CA91773 U.S.A.",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30042000916 人用醫藥製劑，含有其他抗生素者Medicaments, containing other antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812200102",
            "成分名稱": "AMPHOTERICIN B",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020233880002-102-10-23.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023388&Seq=007&Type=9"
        },
        {
            "title": "020233880003-102-07-12.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023388&Seq=002&Type=8"
        }
    ]
}